{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:29:13Z","timestamp":1749720553654,"version":"3.40.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.resinv.2024.05.008","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:31:54Z","timestamp":1715949114000},"page":"657-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study"],"prefix":"10.1016","volume":"62","author":[{"given":"Teiko","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Funaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3800-1327","authenticated-orcid":false,"given":"Eriko","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4504-232X","authenticated-orcid":false,"given":"Toru","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Ose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-874X","authenticated-orcid":false,"given":"Yoshikazu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2024.05.008_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.healun.2019.06.015","article-title":"Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis","volume":"38","author":"Khawar","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.resinv.2024.05.008_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/resp.12430","article-title":"Clinical features of 280 hospitalized patients with lymphangioleiomyomatosis in Japan","volume":"20","author":"Hasegawa","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.05.008_bib3","unstructured":"The Japan Society for Transprantation. Fact Book 2022 on Organ Transplantation in Japan. http:\/\/www.asas.or.jp\/jst\/pdf\/factbook\/."},{"key":"10.1016\/j.resinv.2024.05.008_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/crj.13108","article-title":"Favorable survival even with high disease-specific complication rates in lymphangioleiomyomatosis after lung transplantation-long-term follow-up of a Japanese center","volume":"14","author":"Kurosaki","year":"2020","journal-title":"Clin Respir J"},{"key":"10.1016\/j.resinv.2024.05.008_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146749","article-title":"Lung transplantation for lymphangioleiomyomatosis in Japan","volume":"11","author":"Ando","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.05.008_bib6","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.05.008_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2024.05.008_bib8","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.1038\/s41598-022-12314-1","article-title":"Long-term clinical course and progression of lymphangioleiomyomatosis in a single lung transplant referral centre in Korea","volume":"12","author":"Chang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.05.008_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/01.TP.0000064083.02120.2C","article-title":"Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation","volume":"75","author":"King-Biggs","year":"2003","journal-title":"Transplant"},{"key":"10.1016\/j.resinv.2024.05.008_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1053-2498(03)00309-7","article-title":"Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression","volume":"23","author":"Groetzner","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.resinv.2024.05.008_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"Johnson","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.05.008_bib12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.resinv.2024.05.008_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.resinv.2024.05.008_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.healun.2022.09.021","article-title":"Lung transplantation for lymphangioleiomyomatosis","volume":"42","author":"Warrior","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.resinv.2024.05.008_bib15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American thoracic society\/Japanese respiratory society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.05.008_bib16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.chest.2022.05.036","article-title":"Impact of age, menopause, and sirolimus on spontaneous pneumothoraces in lymphangioleiomyomatosis","volume":"162","author":"Cortinas","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.05.008_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.chest.2018.06.016","article-title":"The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis","volume":"155","author":"Gupta","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.05.008_bib18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management","volume":"9","author":"McCarthy","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.05.008_bib19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1164\/rccm.201709-1965ST","article-title":"Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An official American thoracic society\/Japanese respiratory society clinical practice guideline","volume":"196","author":"Gupta","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.05.008_bib20","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.129.5.1274","article-title":"Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications","volume":"129","author":"Almoosa","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.05.008_bib21","article-title":"Lymphangioleiomyomatosis (LAM) presenting as recurrent pneumothorax in an infant with tuberous sclerosis: treated successfully with sirolimus","volume":"2018","author":"Takia","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.resinv.2024.05.008_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13023-018-0915-2","article-title":"Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series","volume":"13","author":"Zhou","year":"2018","journal-title":"Orphan J Rare Dis"},{"key":"10.1016\/j.resinv.2024.05.008_bib23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s13023-021-02081-z","article-title":"Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis","volume":"16","author":"Sakurai","year":"2021","journal-title":"Orphan J Rare Dis"},{"key":"10.1016\/j.resinv.2024.05.008_bib24","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1513\/AnnalsATS.201605-335OC","article-title":"Efficacy and safety of long-term sirolimus therapy for Asian patients with lymphangioleiomyomatosis","volume":"13","author":"Takada","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2024.05.008_bib25","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1016\/j.healun.2020.01.334","article-title":"Continuation of mTOR inhibition in LAM patients listed for lung transplant is safe","volume":"39","author":"Warrior","year":"2020","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.resinv.2024.05.008_bib26","article-title":"A retrospective study of lung transplantation in patients with lymphangioleiomyomatosis: challenges and outcomes","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2024.05.008_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106779","article-title":"A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant","volume":"195","author":"Warrior","year":"2022","journal-title":"Respir Med"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T08:03:30Z","timestamp":1730534610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534524000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2212534524000832"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2024.05.008","relation":{},"ISSN":["2212-5345"],"issn-type":[{"type":"print","value":"2212-5345"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2024.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}